(Q24610409)
Statements
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (English)
0 references
24 August 2010
0 references
103
0 references
668-75
0 references
5
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference